| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet infectious diseases 18 (3), 318-327, 2018 | 5995 | 2018 |
| Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ... The Lancet infectious diseases 14 (6), 498-509, 2014 | 978 | 2014 |
| The global preclinical antibacterial pipeline U Theuretzbacher, K Outterson, A Engel, A Karlén Nature Reviews Microbiology 18 (5), 275-285, 2020 | 680 | 2020 |
| Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, ... The lancet Infectious diseases 18 (4), 391-400, 2018 | 584 | 2018 |
| Pharmacokinetic/pharmacodynamic profile of voriconazole U Theuretzbacher, F Ihle, H Derendorf Clinical pharmacokinetics 45, 649-663, 2006 | 576 | 2006 |
| Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus RL Nation, J Li, O Cars, W Couet, MN Dudley, KS Kaye, JW Mouton, ... The Lancet infectious diseases 15 (2), 225-234, 2015 | 404 | 2015 |
| Tissue concentrations: do we ever learn? JW Mouton, U Theuretzbacher, WA Craig, PM Tulkens, H Derendorf, ... Journal of Antimicrobial Chemotherapy 61 (2), 235-237, 2008 | 383 | 2008 |
| Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials A Huttner, EM Verhaegh, S Harbarth, AE Muller, U Theuretzbacher, ... Journal of Antimicrobial Chemotherapy 70 (9), 2456-2464, 2015 | 333 | 2015 |
| Critical analysis of antibacterial agents in clinical development U Theuretzbacher, K Bush, S Harbarth, M Paul, JH Rex, E Tacconelli, ... Nature Reviews Microbiology 18 (5), 286-298, 2020 | 324 | 2020 |
| Protein binding: do we ever learn? MA Zeitlinger, H Derendorf, JW Mouton, O Cars, WA Craig, D Andes, ... Antimicrobial agents and chemotherapy 55 (7), 3067-3074, 2011 | 299 | 2011 |
| Combination therapy for carbapenem-resistant Gram-negative bacteria M Paul, Y Carmeli, E Durante-Mangoni, JW Mouton, E Tacconelli, ... Journal of Antimicrobial Chemotherapy 69 (9), 2305-2309, 2014 | 266 | 2014 |
| Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective JW Mouton, PG Ambrose, R Canton, GL Drusano, S Harbarth, ... Drug Resistance Updates 14 (2), 107-117, 2011 | 261 | 2011 |
| Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial A Huttner, A Kowalczyk, A Turjeman, T Babich, C Brossier, N Eliakim-Raz, ... Jama 319 (17), 1781-1789, 2018 | 249 | 2018 |
| Analysis of the clinical antibacterial and antituberculosis pipeline U Theuretzbacher, S Gottwalt, P Beyer, M Butler, L Czaplewski, ... The Lancet Infectious Diseases 19 (2), e40-e50, 2019 | 248 | 2019 |
| Global antibacterial resistance: The never-ending story U Theuretzbacher Journal of global antimicrobial resistance 1 (2), 63-69, 2013 | 216 | 2013 |
| Non-traditional antibacterial therapeutic options and challenges U Theuretzbacher, LJV Piddock Cell host & microbe 26 (1), 61-72, 2019 | 215 | 2019 |
| Accelerating resistance, inadequate antibacterial drug pipelines and international responses U Theuretzbacher International journal of antimicrobial agents 39 (4), 295-299, 2012 | 215 | 2012 |
| WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... Lancet Infect Dis 18 (3), 318-327, 2018 | 199 | 2018 |
| Global antimicrobial resistance in Gram-negative pathogens and clinical need U Theuretzbacher Current opinion in microbiology 39, 106-112, 2017 | 192 | 2017 |
| International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious … JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ... Lancet Infect Dis 14 (6), 498-509, 2014 | 175 | 2014 |
